The role of IL-10 in immune regulation during M. tuberculosis infection
暂无分享,去创建一个
[1] Margarida Saraiva,et al. Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.
[2] P. D. Hart,et al. RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.
[3] J. Gerber,et al. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. , 2001, Journal of immunology.
[4] J. Sedgwick,et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.
[5] R. North,et al. The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.
[6] H. Bang,et al. Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity1 , 2009, The Journal of Immunology.
[7] Dinakar,et al. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. , 1994, The Journal of clinical investigation.
[8] J. Ernst,et al. Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.
[9] S. Dorman,et al. Interferon-gamma and interleukin-12 pathway defects and human disease. , 2000, Cytokine & growth factor reviews.
[10] J. Blackwell,et al. Interleukin-4 (IL-4) and IL-10 Collude in Vaccine Failure for Novel Exacerbatory Antigens in Murine Leishmania major Infection , 2005, Infection and Immunity.
[11] J. Friedland,et al. Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. , 2000, Cytokine.
[12] D. Raoult,et al. The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.
[13] R. Rojas,et al. Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. , 1999, Infection and immunity.
[14] F. Deist,et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.
[15] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[16] Gisen Kim,et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.
[17] Richard A. Flavell,et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.
[18] A. Yahagi,et al. Suppressed induction of mycobacterial antigen-specific Th1-type CD4+ T cells in the lung after pulmonary mycobacterial infection. , 2010, International immunology.
[19] M. Newport,et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. , 2004, Lancet.
[20] W. Alexander,et al. General Nature of the STAT3-Activated Anti-Inflammatory Response1 , 2006, The Journal of Immunology.
[21] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[22] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[23] J. Kolls,et al. Th17 cells and mucosal host defense. , 2007, Seminars in immunology.
[24] J. F. Brown,et al. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice , 1994, Infection and immunity.
[25] I. Orme,et al. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.
[26] B. Ryffel,et al. Increased resistance to mycobacterial infection in the absence of interleukin‐10 , 2000, Immunology.
[27] S. Behar,et al. In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.
[28] R. Rojas,et al. Regulation of Human CD4+ αβ T-Cell-Receptor-Positive (TCR+) and γδ TCR+ T-Cell Responses to Mycobacterium tuberculosis by Interleukin-10 and Transforming Growth Factor β , 1999, Infection and Immunity.
[29] B. Musellim,et al. Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. , 2008, Journal of clinical immunology.
[30] S. Swain,et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.
[31] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[32] J. Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.
[33] S. Ehlers,et al. Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity1 , 2009, The Journal of Immunology.
[34] M. Newport,et al. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.
[35] R. North. Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.
[36] R. Wood,et al. Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[37] I. Orme,et al. Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. , 2011, Tuberculosis.
[38] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[39] Ilkka Julkunen,et al. Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.
[40] I. Orme,et al. Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.
[41] J. Casanova,et al. Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.
[42] B. Ryffel,et al. Enhanced Immune Response in Mycobacterium bovis Bacille Calmette Guerin (BCG)-Infected IL-10-Deficient Mice , 2002, Clinical chemistry and laboratory medicine.
[43] L. Groebe,et al. Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model , 2010, European journal of immunology.
[44] S. Dorman,et al. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.
[45] A. Pacheco,et al. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study , 2008, Human Genetics.
[46] L. García,et al. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. , 2006, Tuberculosis.
[47] A. Apt,et al. Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice , 2005, Infection and Immunity.
[48] P. Linsley,et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.
[49] S. Kaufmann,et al. New insights into the function of granulomas in human tuberculosis , 2006, The Journal of pathology.
[50] JoAnne L. Flynn,et al. Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.
[51] G. Cheng,et al. Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages , 2010, The Journal of Immunology.
[52] J. Son,et al. Polymorphisms of interleukin‐10 and tumour necrosis factor‐α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis , 2007, Respirology.
[53] Yu-Jin Jung,et al. Increased interleukin‐10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice , 2003, Immunology.
[54] Alan D. Roberts,et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.
[55] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Blackwell,et al. IL-10 from Regulatory T Cells Determines Vaccine Efficacy in Murine Leishmania major Infection1 , 2005, The Journal of Immunology.
[57] A. Sher,et al. IL-10 Is Required for Prevention of Necrosis in the Small Intestine and Mortality in Both Genetically Resistant BALB/c and Susceptible C57BL/6 Mice Following Peroral Infection with Toxoplasma gondii1 , 2000, The Journal of Immunology.
[58] R. Young,et al. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.
[59] R. Appelberg,et al. Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination1 , 2001, The Journal of Immunology.
[60] B. Musellim,et al. Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis , 2008, Journal of Clinical Immunology.
[61] N. Reiling,et al. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. , 2008, Immunology letters.
[62] J. Gerber,et al. Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors1 , 2001, The Journal of Immunology.
[63] John Chan,et al. What's good for the host is good for the bug. , 2005, Trends in microbiology.
[64] D. Rennick,et al. Endogenous Inhibition of Antimycobacterial Immunity by IL‐10 Varies between Mycobacterial Species , 2001, Scandinavian journal of immunology.
[65] G. Köhler,et al. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. , 1997, Journal of immunology.
[66] Steven M. Holland,et al. Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.
[67] K. Takatsu,et al. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis , 2010, The Journal of experimental medicine.
[68] G. Trinchieri,et al. CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .
[69] M. Newport,et al. Polymorphism in the Interferon‐γ Receptor‐1 Gene and Susceptibility to Pulmonary Tuberculosis in The Gambia , 2003, Scandinavian journal of immunology.
[70] D. Sacks,et al. CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.
[71] C. Dye,et al. Tuberculosis control in the era of HIV , 2005, Nature Reviews Immunology.
[72] Xin Xu,et al. Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice. , 2010, Arthritis and rheumatism.
[73] J. Ernst,et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs , 2008, The Journal of experimental medicine.
[74] Alicia González,et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. , 2003, American journal of respiratory and critical care medicine.
[75] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[76] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[77] A. O’Garra,et al. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.
[78] S. Khader,et al. IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.
[79] M. Reed,et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.
[80] J. Flynn,et al. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.
[81] S. Akira,et al. Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.
[82] I. Orme,et al. The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.
[83] R. Appelberg,et al. IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy1 , 2007, The Journal of Immunology.
[84] Joseph Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .
[85] N. Boéchat,et al. Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor β (TGF-β) and Analysis of TGF-β Receptors I and II in Active Tuberculosis , 2004, Infection and Immunity.
[86] A. Sher,et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. , 1999, Immunity.
[87] H. Whittle,et al. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[88] M. Newport,et al. Clinical features of dominant and recessive interferon γ receptor 1 deficiencies , 2004, The Lancet.
[89] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[90] R. Coffman,et al. Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy , 2002, Infection and Immunity.
[91] A. Sher,et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.
[92] J. Wain,et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion , 2006, Proceedings of the National Academy of Sciences.
[93] A. Sher,et al. Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo , 2010, The Journal of Immunology.
[94] J. Casanova,et al. Inborn errors of interferon (IFN)‐mediated immunity in humans: insights into the respective roles of IFN‐α/β, IFN‐γ, and IFN‐λ in host defense , 2008, Immunological reviews.
[95] L. Bermudez,et al. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice , 1993, Infection and immunity.
[96] C. Hawrylowicz,et al. Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.
[97] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[98] A. Rudensky,et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.
[99] Alan D. Roberts,et al. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. , 1995, Immunology.
[100] S. Ehlers,et al. Granulocytes Accelerated and Enhanced Recruitment of Tuberculosis in Mice Causally Involves Genetically Determined Susceptibility To , 2022 .
[101] S. Hickman,et al. Mycobacterium tuberculosis Induces Differential Cytokine Production from Dendritic Cells and Macrophages with Divergent Effects on Naive T Cell Polarization1 , 2002, The Journal of Immunology.
[102] V. Boussiotis,et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.
[103] J. Flynn,et al. Effects of aminoguanidine on latent murine tuberculosis. , 1998, Journal of immunology.
[104] B. Bloom,et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.
[105] G. Bancroft,et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.
[106] S. Holland. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity , 2007, Immunologic research.
[107] C. Demangel,et al. Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.
[108] David M Tobin,et al. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis , 2008, Cellular microbiology.
[109] S. Gordon,et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.
[110] A. Cooper,et al. IL-17 and Th17 cells in tuberculosis. , 2010, Cytokine & growth factor reviews.
[111] S. Dorman,et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.
[112] H. Mollenkopf,et al. The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.
[113] A. Sher,et al. MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.
[114] Bodo Grimbacher,et al. STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.
[115] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[116] Y. Belkaid,et al. Regulatory ripples , 2010, Nature Immunology.
[117] J. Flynn,et al. Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.
[118] N. Juffermans,et al. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment , 1999, Clinical and experimental immunology.
[119] S. Dorman,et al. Interferon-γ and interleukin-12 pathway defects and human disease , 2000 .
[120] Genhong Cheng,et al. Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production1 , 2007, The Journal of Immunology.
[121] J. Casanova,et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.
[122] A. Crampin,et al. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. , 2004, The American journal of tropical medicine and hygiene.
[123] Y. Belkaid,et al. The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.
[124] P. Ghazal,et al. Hijacking and exploitation of IL-10 by intracellular pathogens. , 2001, Trends in microbiology.
[125] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[126] JoAnne L. Flynn,et al. Fate of Mycobacterium tuberculosis within Murine Dendritic Cells , 2001, Infection and Immunity.
[127] J. Keane,et al. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.
[128] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[129] S. Akira,et al. MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis , 2003, The Journal of experimental medicine.
[130] H. Shin,et al. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis , 2005, Experimental & Molecular Medicine.
[131] J. Delgado,et al. Ethnic-specific genetic associations with pulmonary tuberculosis. , 2002, The Journal of infectious diseases.
[132] R. Hernández-Pando,et al. Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes , 2004, Immunology.
[133] C. Leclerc,et al. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.
[134] J. Abrams,et al. Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.
[135] B. Foxwell,et al. Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages , 2004, The Journal of Immunology.
[136] M. Fei,et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.
[137] P. R. Narayanan,et al. Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. , 2007, The Indian journal of medical research.
[138] G. Kaplan,et al. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[139] F. Powrie,et al. Regulatory T cells reinforce intestinal homeostasis. , 2009, Immunity.
[140] K. Tanaka,et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[141] L. Ramakrishnan,et al. The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection , 2009, Cell.
[142] J. Casanova,et al. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. , 2004, The Journal of infectious diseases.
[143] M. Quail,et al. Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.
[144] S. Akira,et al. Microbial Recognition Via Toll-Like Receptor-Dependent and -Independent Pathways Determines the Cytokine Response of Murine Dendritic Cell Subsets to CD40 Triggering1 , 2002, The Journal of Immunology.
[145] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[146] J. Pedrosa,et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis , 2010, The Journal of experimental medicine.
[147] G. Kaplan,et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[148] D. McGavern,et al. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection , 2008, The Journal of experimental medicine.
[149] I. Orme,et al. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. , 2009, Tuberculosis.
[150] D. Flaherty,et al. Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.
[151] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[152] Frank Kaiser,et al. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells , 2009, The Journal of experimental medicine.
[153] Ching Li,et al. A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.
[154] B. Ryffel,et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. , 2004, The Journal of clinical investigation.
[155] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[156] G. Kaplan,et al. Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling , 2010, Science Signaling.
[157] John Chan,et al. Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.
[158] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[159] U. Schaible,et al. Mycobacterium‐containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. , 1996, The EMBO journal.
[160] R. Appelberg,et al. Blocking the Receptor for Interleukin 10 Protects Mice from Lethal Listeriosis , 2001, Antimicrobial Agents and Chemotherapy.
[161] N. Boéchat,et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. , 2004, Infection and immunity.
[162] L. Teyton,et al. Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.
[163] T. Slifer,et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. , 1997, Journal of immunology.
[164] A. Sher,et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.
[165] J. Abastado,et al. Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells 1 , 2003, The Journal of Immunology.
[166] S. Nakae,et al. Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung , 2010, The Journal of Immunology.
[167] M. Conde,et al. TheMycobacterium tuberculosis Complex-Restricted Genecfp32 Encodes an Expressed Protein That Is Detectable inTuberculosis Patients and Is Positively Correlated with PulmonaryInterleukin-10 , 2003, Infection and Immunity.
[168] Timothy J. Sturgeon,et al. Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load , 2010, PloS one.
[169] A. Myers,et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.
[170] S. Kaufmann,et al. Iron Chelation Via Deferoxamine Exacerbates Experimental Salmonellosis Via Inhibition of the Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Respiratory Burst , 2002, The Journal of Immunology.
[171] Alicia González,et al. Interferon-γ and Interleukin-10 Gene Polymorphisms in Pulmonary Tuberculosis , 2003 .
[172] S. Fortune,et al. Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories , 2010, Journal of bacteriology.
[173] Y. Belkaid,et al. Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection , 2005, Infection and Immunity.
[174] H. Oral,et al. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. , 2006, Cytokine.